SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lupus navigator program aims to close care gaps for minority patients
Disease control CompletedThis study tested a program where a patient navigator helped minority adults with lupus overcome barriers to care, like scheduling appointments, arranging transportation, and understanding their health. The goal was to see if this support could improve quality of life and medicat…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
New hope for lupus brain fog: experimental drug shows promise in trial
Disease control CompletedThis study tested an experimental drug called EG-501 for people with lupus who experience cognitive impairment, often called "brain fog." The trial involved 131 participants who received either the drug or a placebo over 14 weeks. The goal was to see if EG-501 could safely improv…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
New hope for lupus patients: two experimental drugs show promise in reducing disease activity
Disease control CompletedThis study tested two experimental drugs, VAY736 and CFZ533, in 107 adults with systemic lupus erythematosus (SLE). The goal was to see if these drugs could reduce lupus symptoms and allow patients to lower their steroid use. Participants received either one of the drugs or a pla…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
Real-World lupus study reveals how new drug performs outside clinical trials
Disease control CompletedThis study looked at 152 adults with systemic lupus erythematosus (SLE) who started taking anifrolumab during its first year on the market in Spain. Researchers tracked their disease activity, flare-ups, and remission rates using standard medical records. The goal was to see how …
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Lupus patients find relief through online coaching program
Symptom relief CompletedThis completed study tested a health coach-led online program for 36 women with lupus. The program included 8 group sessions and 2 individual sessions to help participants set personal health goals and manage symptoms like fatigue, pain, and brain fog. Researchers measured satisf…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 23, 2026 11:57 UTC
-
Lupus gene hunt in kids could unlock disease secrets
Knowledge-focused CompletedThis study looked at 271 children and adults with lupus to find genetic mutations linked to the disease. Researchers focused on families with multiple lupus cases or unusual symptoms. The goal was to better understand what causes lupus and how it affects the immune system, which …
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Lupus study aims to unlock secrets of immune system attacks
Knowledge-focused CompletedThis study looked at how the immune system behaves in people with lupus (SLE) and mixed connective tissue disease (MCTD). Researchers measured immune cell responses and tracked disease activity over time. The goal was to better understand these long-term autoimmune diseases, whic…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:24 UTC
-
Researchers build database to track APS and lupus patients
Knowledge-focused CompletedThis study created a registry to collect medical information from 868 people with Anti-Phospholipid Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE). The goal was to gather data on these conditions, not to test a new treatment. Participants were adults diagnosed with APS …
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 27, 2026 12:03 UTC